≡ Risteys
R8

Documentation Changelog GitHub Contact & Feedback

L02BA Anti-estrogens

PheWeb

RX_L02BA

No definition available.

Endpoint definition

↥
FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC L02BA

4905

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

4024

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

4024

diagram downward connector

Include endpoints None

4024

diagram downward connector
RX_L02BA

Extra metadata

First used in FinnGen datafreeze DF3

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 4024 3948 76
Unadjusted prevalence (%) 1.13 1.99 0.05
Mean age at first event (years) 56.60 56.52 60.62

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.06 4.03 [2.83, 5.74] 1.2e-14 475
15 years 0.02 2.65 [1.95, 3.58] 3.1e-10 221
5 years 0.01 6.41 [4.85, 8.46] 2.7e-39 170
1 year 0.00 7.32 [4.89, 10.93] 2.8e-22 35

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: RX_L02BA – L02BA Anti-estrogens
GWS hits:

Survival analyses between endpoints

↥

Plot

before L02BA Anti-estrogens
after L02BA Anti-estrogens

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after L02BA Anti-estrogens

↥